Literature DB >> 14526067

Neuroscience. Stout guards of the central nervous system.

R Mechoulam1, A H Lichtman.   

Abstract

Endocannabinoids have paradoxical effects on the mammalian nervous system: Sometimes they block neuronal excitability and other times they augment it. In their Perspective, Mechoulam and Lichtman discuss new work (Marsicano et al.) showing that activation of the cannabinoid receptor CB1 by the endocannabinoid anandamide protects against excitotoxic damage in a mouse model of kainic acid-induced epilepsy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526067     DOI: 10.1126/science.1091256

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  14 in total

Review 1.  In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans.

Authors:  Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11       Impact factor: 9.236

2.  Selective reduction of cholecystokinin-positive basket cell innervation in a model of temporal lobe epilepsy.

Authors:  Megan S Wyeth; Nianhui Zhang; Istvan Mody; Carolyn R Houser
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

3.  Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome.

Authors:  Bo-Zong Shao; Wei Wei; Ping Ke; Zhe-Qi Xu; Jv-Xiang Zhou; Chong Liu
Journal:  CNS Neurosci Ther       Date:  2014-12       Impact factor: 5.243

4.  The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration.

Authors:  John C Ashton; Michelle Glass
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

5.  Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hypothalamus.

Authors:  Shenglong Zou; Rishi K Somvanshi; Seungil Paik; Ujendra Kumar
Journal:  J Mol Neurosci       Date:  2014-07-08       Impact factor: 3.444

Review 6.  How do seizures stop?

Authors:  Fred A Lado; Solomon L Moshé
Journal:  Epilepsia       Date:  2008-05-21       Impact factor: 5.864

Review 7.  Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.

Authors:  Javier Fernández-Ruiz; María A Moro; José Martínez-Orgado
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 8.  Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis.

Authors:  Caren Armstrong; Robert J Morgan; Ivan Soltesz
Journal:  Epilepsia       Date:  2009-07-01       Impact factor: 5.864

9.  AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity.

Authors:  Stephan Guggenhuber; Krisztina Monory; Beat Lutz; Matthias Klugmann
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

10.  A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.

Authors:  Francisco J Carrillo-Salinas; Carmen Navarrete; Miriam Mecha; Ana Feliú; Juan A Collado; Irene Cantarero; María L Bellido; Eduardo Muñoz; Carmen Guaza
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.